Considering the correlation between pretreatment sPD-1 levels and quantity of tumor infiltrating PD-1+ T cells in our cohort, we speculate that increased sPD-1 levels can indicate systemic inflammation provoked by inflammatory tumor cells. Here, PDCD1 is linked to neoplasm.